# Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea

> **NCT04915924** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 358 (actual)

## Conditions studied

- Advanced Heart Failure

## Interventions

- **DEVICE:** HeartMate 3™ left ventricular assist system (HM3 LVAS)

## Key facts

- **NCT ID:** NCT04915924
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-30
- **Primary completion:** 2024-06-02
- **Final completion:** 2024-06-02
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2024-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04915924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04915924, "Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04915924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*